Why RenovoRx Inc (RNXT) Stock Is Rising
As of 2026-08-31, RenovoRx Inc (RNXT) has a next-year EPS growth estimate of 46.67%. Featured in our EPS revision report on 2026-08-31.
Why RNXT Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised RenovoRx Inc's next-year EPS growth estimate from 41.12% to 46.67% on 2026-08-28.
- ·Current-Year Growth: Projected at 17.97%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 46.67%
- EPS growth this year
- 17.97%
- EPS next quarter (est)
- -$0.06
- Last price
- $1.91
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-31 | 46.67% | 17.97% | -$0.06 | $1.91 |
| 2026-08-30 | 46.67% | 17.97% | -$0.06 | $1.67 |
| 2026-08-29 | 46.67% | 17.97% | -$0.06 | $1.67 |
| 2026-08-28 | 46.67% | 17.97% | -$0.06 | $1.67 |
| 2026-08-27 | 41.12% | 16.41% | -$0.06 | $1.48 |
| 2026-08-26 | 41.12% | 16.41% | -$0.06 | $1.49 |
| 2026-08-25 | 41.12% | 16.41% | -$0.06 | $1.42 |
| 2026-08-24 | 41.12% | 16.41% | -$0.06 | $1.25 |
| 2026-08-23 | 41.12% | 16.41% | -$0.06 | $1.32 |
| 2026-08-21 | 41.12% | 16.41% | -$0.06 | $1.32 |
| 2026-08-20 | 41.12% | 16.41% | -$0.06 | $1.32 |
| 2026-08-19 | 41.12% | 16.41% | -$0.06 | $1.32 |
| 2026-08-18 | 43.40% | 17.19% | -$0.06 | $1.17 |
| 2026-08-17 | 43.40% | 17.19% | -$0.06 | $1.20 |
| 2026-08-16 | 43.40% | 17.19% | -$0.06 | $1.40 |
| 2026-08-14 | 43.40% | 17.19% | -$0.06 | $1.40 |
| 2026-08-13 | 50.85% | 7.81% | -$0.07 | $1.26 |
| 2026-08-12 | 50.85% | 7.81% | -$0.07 | $1.12 |
| 2026-08-11 | 50.85% | 7.81% | -$0.07 | $1.15 |
| 2026-08-10 | 50.85% | 7.81% | -$0.07 | $1.16 |
| 2026-08-09 | 50.85% | 7.81% | -$0.07 | $1.12 |
| 2026-08-07 | 50.85% | 7.81% | -$0.07 | $1.12 |
| 2026-08-06 | 50.85% | 7.81% | -$0.07 | $1.15 |
| 2026-08-05 | 50.85% | 7.81% | -$0.07 | $1.06 |
| 2026-08-04 | 50.85% | 7.81% | -$0.07 | $1.04 |
| 2026-08-03 | 50.85% | 7.81% | -$0.07 | $1.06 |
| 2026-08-02 | 50.85% | 7.81% | -$0.07 | $0.96 |
| 2026-07-31 | 50.85% | 7.81% | -$0.07 | $0.96 |
| 2026-07-30 | 50.85% | 7.81% | -$0.07 | $0.94 |
| 2026-07-29 | 50.85% | 7.81% | -$0.07 | $0.90 |
Reports Featuring RNXT
Recent News
- RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath Device for Targeted, Local Drug-Delivery via the Vasa VasorumGlobeNewswire
- RenovoRx Inc (RNXT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...GuruFocus.com
- RenovoRx Reports Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- Earnings To Watch: RenovoRx Inc (RNXT) Reports Q1 2026 ResultGuruFocus.com
- RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of EnrollmentGlobeNewswire
Screen Performance
Aggregate stats across all 2024 tickers our top-EPS-revision screen has flagged over the past 152 days.
- Median return since detection
- +1.7%
- % of tickers in the green
- 54%
- Median return on winners
- +20.6%
- Large revisions captured
- 1641
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did RenovoRx Inc (RNXT) stock go up recently?▾
RenovoRx Inc (RNXT) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 41.12% to 46.67% on 2026-08-28. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is RenovoRx Inc's next-year EPS growth estimate?▾
As of 2026-08-31, RenovoRx Inc (RNXT) has a next-year EPS growth estimate of 46.67%, based on analyst consensus.
When was the latest EPS estimate revision for RNXT?▾
The most recent revision occurred on 2026-08-28, when analysts adjusted the next-year EPS growth estimate from 41.12% to 46.67%.
What sector and industry does RenovoRx Inc belong to?▾
RenovoRx Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RNXT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. RenovoRx Inc (RNXT) appears here because it was detected by our daily top-EPS-revision-performer screen.